Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedFeb 27, 2026
DataAggregated Company Financials
Companies18
- 7D1.1%
- 3M0.2%
- 1Y-18.7%
- YTD0.3%
The Healthcare industry is up 1.1% in the last week, with Recordati Industria Chimica e Farmaceutica up 1.4%. In contrast, the industry has lost 19% in the last 12 months. As for the next few years, earnings are expected to grow by 11% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 28 Feb 2026 | €20.9b | €8.8b | €886.9m | 21.8x | 23.5x | 2.4x |
| Mon, 26 Jan 2026 | €20.8b | €8.8b | €886.9m | 21.4x | 23.5x | 2.4x |
| Wed, 24 Dec 2025 | €20.7b | €8.8b | €886.9m | 20.5x | 23.4x | 2.3x |
| Fri, 21 Nov 2025 | €20.3b | €8.8b | €887.5m | 18.9x | 22.9x | 2.3x |
| Sun, 19 Oct 2025 | €22.2b | €8.8b | €896.1m | 20.5x | 24.8x | 2.5x |
| Tue, 16 Sep 2025 | €22.7b | €8.7b | €894.6m | 20x | 25.4x | 2.6x |
| Thu, 14 Aug 2025 | €22.4b | €8.7b | €902.9m | 19.4x | 24.8x | 2.6x |
| Sat, 12 Jul 2025 | €24.7b | €8.6b | €941.3m | 20.1x | 26.3x | 2.9x |
| Mon, 09 Jun 2025 | €23.9b | €25.2b | €985.5m | 19.6x | 24.2x | 0.9x |
| Wed, 07 May 2025 | €23.2b | €20.1b | €904.9m | 18.5x | 25.6x | 1.2x |
| Fri, 04 Apr 2025 | €22.2b | €20.1b | €906.3m | 16.8x | 24.4x | 1.1x |
| Sun, 02 Mar 2025 | €24.7b | €20.0b | €821.4m | 23.3x | 30.1x | 1.2x |
| Tue, 28 Jan 2025 | €25.5b | €7.9b | €829.1m | 23.6x | 30.8x | 3.2x |
| Thu, 26 Dec 2024 | €24.3b | €18.7b | €1.4b | 21x | 17.1x | 1.3x |
| Sat, 23 Nov 2024 | €24.7b | €19.0b | €1.4b | 19x | 17.3x | 1.3x |
| Mon, 21 Oct 2024 | €26.0b | €18.9b | €1.4b | 18.1x | 18.8x | 1.4x |
| Wed, 18 Sep 2024 | €25.2b | €18.9b | €1.4b | 16.1x | 18x | 1.3x |
| Fri, 16 Aug 2024 | €25.1b | €18.9b | €1.4b | 16.4x | 18.1x | 1.3x |
| Sun, 14 Jul 2024 | €26.1b | €18.8b | €1.4b | 17.3x | 18.8x | 1.4x |
| Tue, 11 Jun 2024 | €26.5b | €18.8b | €1.4b | 17x | 19.1x | 1.4x |
| Thu, 09 May 2024 | €26.2b | €18.7b | €1.4b | 19.3x | 18.9x | 1.4x |
| Sat, 06 Apr 2024 | €24.6b | €18.7b | €1.4b | 19.1x | 17.9x | 1.3x |
| Mon, 04 Mar 2024 | €25.4b | €18.6b | €1.4b | 18.4x | 18.1x | 1.4x |
| Wed, 31 Jan 2024 | €24.6b | €18.6b | €1.4b | 19.5x | 17.7x | 1.3x |
| Fri, 29 Dec 2023 | €24.9b | €18.6b | €1.4b | 18.6x | 17.9x | 1.3x |
| Sun, 26 Nov 2023 | €23.1b | €18.6b | €1.4b | 18.5x | 16.5x | 1.2x |
| Tue, 24 Oct 2023 | €22.3b | €18.6b | €1.4b | 16.3x | 15.4x | 1.2x |
| Thu, 21 Sep 2023 | €23.9b | €17.3b | €1.1b | 16.4x | 21x | 1.4x |
| Sat, 19 Aug 2023 | €23.1b | €17.3b | €1.1b | 15.3x | 20.3x | 1.3x |
| Mon, 17 Jul 2023 | €23.6b | €7.7b | €822.5m | 16.3x | 28.7x | 3.1x |
| Wed, 14 Jun 2023 | €25.2b | €7.7b | €822.5m | 19.6x | 30.6x | 3.3x |
| Fri, 12 May 2023 | €25.1b | €7.6b | €825.6m | 22.1x | 30.4x | 3.3x |
| Sun, 09 Apr 2023 | €23.4b | €7.5b | €823.6m | 21.6x | 28.4x | 3.1x |
| Tue, 07 Mar 2023 | €23.8b | €7.5b | €867.3m | 24.8x | 27.5x | 3.2x |
Price to Earnings Ratio
27.5x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.6x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 3.08% | |
| Healthcare | 1.05% | |
| Healthtech | 5.39% | |
| Life Sciences | 5.00% | |
| Healthcare Services | 1.78% | |
| Pharma | 1.43% | |
| Medical Equipment | 0.04% | |
| Biotech | -2.72% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.7x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Biotech industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 76% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIA DiaSorin | €71.20 | 1.4% +€52.9m | -29.8% | PE20.9x | |
| REC Recordati Industria Chimica e Farmaceutica | €48.42 | 0.5% +€49.1m | -10.8% | PE24.5x | |
| GPI GPI | €17.36 | 3.0% +€14.4m | 93.3% | PE31.6x | |
| GHC Garofalo Health Care | €5.63 | 2.6% +€12.4m | 13.5% | PE18.9x | |
| FF Fine Foods & Pharmaceuticals N.T.M | €11.55 | 0.4% +€1.2m | 74.5% | PE22.6x |
